[HTML][HTML] Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
S Stintzing, S Tejpar, P Gibbs, L Thiebach… - European Journal of …, 2017 - Elsevier
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
S Stintzing, S Tejpar, P Gibbs… - … Journal of Cancer, 2017 - epub.ub.uni-muenchen.de
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
[PDF][PDF] Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
S Stintzinga, S Tejparb, P Gibbsc… - Eur J …, 2017 - minerva-access.unimelb.edu.au
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
[引用][C] Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
S Stintzing, S Tejpar, P Gibbs, L Thiebach… - European Journal of …, 2017 - cir.nii.ac.jp
Understanding the role of primary tumour localisation in colorectal cancer treatment and
outcomes | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
outcomes | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes.
S Stintzing, S Tejpar, P Gibbs, L Thiebach… - European Journal of …, 2017 - europepmc.org
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
[PDF][PDF] Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
S Stintzing, S Tejpar, P Gibbs… - European Journal of …, 2017 - cyberleninka.org
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
[HTML][HTML] Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
S Stintzing, S Tejpar, P Gibbs, L Thiebach… - European Journal of …, 2017 - ejcancer.com
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
S Stintzing, S Tejpar, P Gibbs… - European journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
[HTML][HTML] Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
S Stintzing, S Tejpar, P Gibbs, L Thiebach… - European journal of …, 2017 - ncbi.nlm.nih.gov
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
[PDF][PDF] Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
S Stintzing, S Tejpar, P Gibbs, L Thiebach… - European Journal of …, 2017 - core.ac.uk
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …
outcomes and clinical responses and poor prognosis. CRCs can be characterised by their …